These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

495 related items for PubMed ID: 10647603

  • 1. Imaging serotonin and dopamine transporters with 123I-beta-CIT SPECT: binding kinetics and effects of normal aging.
    Pirker W, Asenbaum S, Hauk M, Kandlhofer S, Tauscher J, Willeit M, Neumeister A, Praschak-Rieder N, Angelberger P, Brücke T.
    J Nucl Med; 2000 Jan; 41(1):36-44. PubMed ID: 10647603
    [Abstract] [Full Text] [Related]

  • 2. Iodine-123-beta-CIT and iodine-123-FPCIT SPECT measurement of dopamine transporters in healthy subjects and Parkinson's patients.
    Seibyl JP, Marek K, Sheff K, Zoghbi S, Baldwin RM, Charney DS, van Dyck CH, Innis RB.
    J Nucl Med; 1998 Sep; 39(9):1500-8. PubMed ID: 9744331
    [Abstract] [Full Text] [Related]

  • 3. Reproducibility of iodine-123-beta-CIT SPECT brain measurement of dopamine transporters.
    Seibyl JP, Laruelle M, van Dyck CH, Wallace E, Baldwin RM, Zoghbi S, Zea-Ponce Y, Neumeyer JL, Charney DS, Hoffer PB, Innis RB.
    J Nucl Med; 1996 Feb; 37(2):222-8. PubMed ID: 8667048
    [Abstract] [Full Text] [Related]

  • 4. SPECT imaging of dopamine transporters in human brain with iodine-123-fluoroalkyl analogs of beta-CIT.
    Abi-Dargham A, Gandelman MS, DeErausquin GA, Zea-Ponce Y, Zoghbi SS, Baldwin RM, Laruelle M, Charney DS, Hoffer PB, Neumeyer JL, Innis RB.
    J Nucl Med; 1996 Jul; 37(7):1129-33. PubMed ID: 8965183
    [Abstract] [Full Text] [Related]

  • 5. Serotonin transporters in the midbrain of Parkinson's disease patients: a study with 123I-beta-CIT SPECT.
    Kim SE, Choi JY, Choe YS, Choi Y, Lee WY.
    J Nucl Med; 2003 Jun; 44(6):870-6. PubMed ID: 12791812
    [Abstract] [Full Text] [Related]

  • 6. [123I] beta-CIT, a tracer for dopamine and serotonin re-uptake sites: preparation and preliminary SPECT studies in humans.
    Bergström KA, Kuikka JT, Ahonen A, Vanninen E.
    J Nucl Biol Med (1991); 1994 Dec; 38(4 Suppl 1):128-31. PubMed ID: 7632756
    [Abstract] [Full Text] [Related]

  • 7. Age-related decline in striatal dopamine transporter binding with iodine-123-beta-CITSPECT.
    van Dyck CH, Seibyl JP, Malison RT, Laruelle M, Wallace E, Zoghbi SS, Zea-Ponce Y, Baldwin RM, Charney DS, Hoffer PB.
    J Nucl Med; 1995 Jul; 36(7):1175-81. PubMed ID: 7790941
    [Abstract] [Full Text] [Related]

  • 8. SPECT imaging of dopamine and serotonin transporters with [123I]beta-CIT: pharmacological characterization of brain uptake in nonhuman primates.
    Laruelle M, Baldwin RM, Malison RT, Zea-Ponce Y, Zoghbi SS, al-Tikriti MS, Sybirska EH, Zimmermann RC, Wisniewski G, Neumeyer JL.
    Synapse; 1993 Apr; 13(4):295-309. PubMed ID: 7683143
    [Abstract] [Full Text] [Related]

  • 9. Test/retest reproducibility of iodine-123-betaCIT SPECT brain measurement of dopamine transporters in Parkinson's patients.
    Seibyl JP, Marek K, Sheff K, Baldwin RM, Zoghbi S, Zea-Ponce Y, Charney DS, van Dyck CH, Hoffer PB, Innis RB.
    J Nucl Med; 1997 Sep; 38(9):1453-9. PubMed ID: 9293807
    [Abstract] [Full Text] [Related]

  • 10. SPECT imaging of dopamine and serotonin transporters with [123I]beta-CIT. Binding kinetics in the human brain.
    Brücke T, Kornhuber J, Angelberger P, Asenbaum S, Frassine H, Podreka I.
    J Neural Transm Gen Sect; 1993 Sep; 94(2):137-46. PubMed ID: 8110440
    [Abstract] [Full Text] [Related]

  • 11. Differential kinetics of [123I]beta-CIT binding to dopamine and serotonin transporters.
    Fujita M, Takatoku K, Matoba Y, Nishiura M, Kobayashi K, Inoue O, Nishimura T.
    Eur J Nucl Med; 1996 Apr; 23(4):431-6. PubMed ID: 8612664
    [Abstract] [Full Text] [Related]

  • 12. Evaluation of the monoamine uptake site ligand [123I]methyl 3 beta-(4-iodophenyl)-tropane-2 beta-carboxylate ([123I]beta-CIT) in non-human primates: pharmacokinetics, biodistribution and SPECT brain imaging coregistered with MRI.
    Baldwin RM, Zea-Ponce Y, Zoghbi SS, Laurelle M, al-Tikriti MS, Sybirska EH, Malison RT, Neumeyer JL, Milius RA, Wang S.
    Nucl Med Biol; 1993 Jul; 20(5):597-606. PubMed ID: 8358345
    [Abstract] [Full Text] [Related]

  • 13. SPECT-evaluation of the monoamine uptake site ligand [123I](1R)-2-beta-carbomethoxy-3-beta-(4-iodophenyl)-tropane ([123I]beta-CIT) in untreated patients with suspicion of Parkinson disease.
    Eising EG, Müller TT, Zander C, Kuhn W, Farahati J, Reiners C, Coenen HH.
    J Investig Med; 1997 Oct; 45(8):448-52. PubMed ID: 9394097
    [Abstract] [Full Text] [Related]

  • 14. Iodine-123-N-omega-fluoropropyl-2beta-carbomethoxy-3beta-(4-iod ophenyl)tropane SPECT in healthy controls and early-stage, drug-naive Parkinson's disease.
    Tissingh G, Booij J, Bergmans P, Winogrodzka A, Janssen AG, van Royen EA, Stoof JC, Wolters EC.
    J Nucl Med; 1998 Jul; 39(7):1143-8. PubMed ID: 9669384
    [Abstract] [Full Text] [Related]

  • 15. Comparison of [123I]beta-CIT and [123I]IPCIT as single-photon emission tomography radiotracers for the dopamine transporter in nonhuman primates.
    Scanley BE, al-Tikriti MS, Gandelman MS, Laruelle M, Zea-Ponce Y, Baldwin RM, Zoghbi SS, Hoffer PB, Charney DS, Wang S.
    Eur J Nucl Med; 1995 Jan; 22(1):4-11. PubMed ID: 7698153
    [Abstract] [Full Text] [Related]

  • 16. SPECT measurement of iodine-123-beta-CIT binding to dopamine and serotonin transporters in Parkinson's disease: correlation with symptom severity.
    Kim SE, Lee WY, Choe YS, Kim JH.
    Neurol Res; 1999 Apr; 21(3):255-61. PubMed ID: 10319333
    [Abstract] [Full Text] [Related]

  • 17. A new model for separation between brain dopamine and serotonin transporters in 123I-beta-CIT SPECT measurements: normal values and sex and age dependence.
    Ryding E, Lindström M, Brådvik B, Grabowski M, Bosson P, Träskman-Bendz L, Rosén I.
    Eur J Nucl Med Mol Imaging; 2004 Aug; 31(8):1114-8. PubMed ID: 15014902
    [Abstract] [Full Text] [Related]

  • 18. Effects of ageing on serotonin transporters in healthy females.
    Kuikka JT, Tammela L, Bergström KA, Karhunen L, Uusitupa M, Tiihonen J.
    Eur J Nucl Med; 2001 Jul; 28(7):911-3. PubMed ID: 11504089
    [Abstract] [Full Text] [Related]

  • 19. Imaging of dopamine transporters with iodine-123-beta-CIT and SPECT in Parkinson's disease.
    Asenbaum S, Brücke T, Pirker W, Podreka I, Angelberger P, Wenger S, Wöber C, Müller C, Deecke L.
    J Nucl Med; 1997 Jan; 38(1):1-6. PubMed ID: 8998140
    [Abstract] [Full Text] [Related]

  • 20. Comparison of iodine-123 labelled 2 beta-carbomethoxy-3 beta-(4-iodophenyl)tropane and 2 beta-carbomethoxy-3 beta-(4-iodophenyl)-N-(3-fluoropropyl)nortropane for imaging of the dopamine transporter in the living human brain.
    Kuikka JT, Bergström KA, Ahonen A, Hiltunen J, Haukka J, Länsimies E, Wang S, Neumeyer JL.
    Eur J Nucl Med; 1995 Apr; 22(4):356-60. PubMed ID: 7607268
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.